188 related articles for article (PubMed ID: 10586338)
1. Treatment of multicentric Castleman's disease complicated by the development of non-Hodgkin's lymphoma with high-dose chemotherapy and autologous peripheral stem-cell support.
Advani R; Warnke R; Rosenberg S
Ann Oncol; 1999 Oct; 10(10):1207-9. PubMed ID: 10586338
[TBL] [Abstract][Full Text] [Related]
2. Clinical features and outcomes in patients with human immunodeficiency virus-negative, Castleman's disease: a single medical center study in Tunisia.
Chabchoub I; Salah RB; Kallel R; Snoussi M; Frikha F; Marzouk S; Boudawara TS; Bahloul Z
Rom J Intern Med; 2024 Mar; 62(1):20-32. PubMed ID: 37948573
[TBL] [Abstract][Full Text] [Related]
3. Plasma cell variant of Castleman's disease occurring concurrently with Hodgkin's disease in the neck.
Frank DK; Charney D; Kashani A
Head Neck; 2001 Feb; 23(2):166-9. PubMed ID: 11303634
[TBL] [Abstract][Full Text] [Related]
4. Report of a case of localized Castleman's disease with progression to malignant lymphoma.
Vasef M; Katzin WE; Mendelsohn G; Reydman M
Am J Clin Pathol; 1992 Dec; 98(6):633-6. PubMed ID: 1462961
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of vascular endothelial growth factor (VEGF) in Castleman's disease: proposed pathomechanism of vascular proliferation in the affected lymph node.
Nishi J; Maruyama I
Leuk Lymphoma; 2000 Jul; 38(3-4):387-94. PubMed ID: 10830746
[TBL] [Abstract][Full Text] [Related]
6. Multicentric Castleman's disease in HIV infection: a systematic review of the literature.
Mylona EE; Baraboutis IG; Lekakis LJ; Georgiou O; Papastamopoulos V; Skoutelis A
AIDS Rev; 2008; 10(1):25-35. PubMed ID: 18385778
[TBL] [Abstract][Full Text] [Related]
7. A successfully treated case of multicentric angiofollicular hyperplasia with oral chemotherapy (Castleman's disease).
Pavlidis NA; Skopouli FN; Bai MC; Bourantas CL
Med Pediatr Oncol; 1990; 18(4):333-5. PubMed ID: 2355894
[TBL] [Abstract][Full Text] [Related]
8. [Castleman's disease].
Larroche C; Cacoub P; Godeau P
Rev Med Interne; 1996; 17(12):1003-13. PubMed ID: 9008748
[TBL] [Abstract][Full Text] [Related]
9. Multicentric Castleman's disease.
Herrada J; Cabanillas FF
Am J Clin Oncol; 1995 Apr; 18(2):180-3. PubMed ID: 7900713
[No Abstract] [Full Text] [Related]
10. Multicentric Castleman's disease in a Ghanaian adult.
Dei-Adomakoh YA; Segbefia C; Ekem I; Taylor A
Ghana Med J; 2013 Jun; 47(2):92-5. PubMed ID: 23966747
[TBL] [Abstract][Full Text] [Related]
11. The management of unicentric and multicentric Castleman's disease: a report of 16 cases and a review of the literature.
Bowne WB; Lewis JJ; Filippa DA; Niesvizky R; Brooks AD; Burt ME; Brennan MF
Cancer; 1999 Feb; 85(3):706-17. PubMed ID: 10091744
[TBL] [Abstract][Full Text] [Related]
12. Renal thrombotic microangiopathy associated with multicentric Castleman's disease. Report of two cases.
Lajoie G; Kumar S; Min KW; Silva FG
Am J Surg Pathol; 1995 Sep; 19(9):1021-8. PubMed ID: 7661275
[TBL] [Abstract][Full Text] [Related]
13. Angiofollicular lymph node hyperplasia (Castleman's disease).
McCarty MJ; Vukelja SJ; Banks PM; Weiss RB
Cancer Treat Rev; 1995 Jul; 21(4):291-310. PubMed ID: 7585657
[TBL] [Abstract][Full Text] [Related]
14. Idiopathic multicentric Castleman's disease: a systematic literature review.
Liu AY; Nabel CS; Finkelman BS; Ruth JR; Kurzrock R; van Rhee F; Krymskaya VP; Kelleher D; Rubenstein AH; Fajgenbaum DC
Lancet Haematol; 2016 Apr; 3(4):e163-75. PubMed ID: 27063975
[TBL] [Abstract][Full Text] [Related]
15. Fifty years of multicentric Castleman's disease.
Waterston A; Bower M
Acta Oncol; 2004; 43(8):698-704. PubMed ID: 15764213
[TBL] [Abstract][Full Text] [Related]
16. [Transitional type of Castleman's disease manifested as the POEMS syndrome].
Tomić I; Plavec G; Tasić O; Ristanović A; Cvijanović V
Vojnosanit Pregl; 2004; 61(4):439-44. PubMed ID: 15552541
[TBL] [Abstract][Full Text] [Related]
17. A patient with Castleman's disease mimicking acute pancreatitis.
Wu J; Lv L; Wang C
Rev Esp Enferm Dig; 2017 Oct; 109(10):737-738. PubMed ID: 28929773
[TBL] [Abstract][Full Text] [Related]
18. Aggressive angiofollicular lymph node hyperplasia (Castleman's disease) treated with high dose melphalan and autologous bone marrow transplantation.
Repetto L; Jaiprakash MP; Selby PJ; Gusterson BA; Williams HJ; McElwain TJ
Hematol Oncol; 1986; 4(3):213-7. PubMed ID: 3533746
[TBL] [Abstract][Full Text] [Related]
19. Coexistence of Hodgkin's disease and giant lymph node hyperplasia of the plasma-cell type (Castleman's disease).
Abdel-Reheim FA; Koss W; Rappaport ES; Arber DA
Arch Pathol Lab Med; 1996 Jan; 120(1):91-6. PubMed ID: 8554455
[TBL] [Abstract][Full Text] [Related]
20. High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells.
Nademanee A; Sniecinski I; Schmidt GM; Dagis AC; O'Donnell MR; Snyder DS; Parker PM; Stein AS; Smith EP; Molina A
J Clin Oncol; 1994 Oct; 12(10):2176-86. PubMed ID: 7523609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
